James B. Weissman

2020

In 2020, James B. Weissman earned a total compensation of $3.3M as Executive Vice President, Chief Operating Officer at Dicerna Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$195,300
Option Awards$1,882,576
Salary$434,000
Stock Awards$781,268
Other$19,468
Total$3,312,612

Weissman received $1.9M in option awards, accounting for 57% of the total pay in 2020.

Weissman also received $195.3K in non-equity incentive plan, $434K in salary, $781.3K in stock awards and $19.5K in other compensation.

Rankings

In 2020, James B. Weissman's compensation ranked 3,524th out of 13,090 executives tracked by ExecPay. In other words, Weissman earned more than 73.1% of executives.

ClassificationRankingPercentile
All
3,524
out of 13,090
73rd
Division
Manufacturing
1,378
out of 5,618
76th
Major group
Chemicals And Allied Products
518
out of 2,251
77th
Industry group
Drugs
449
out of 1,951
77th
Industry
Pharmaceutical Preparations
335
out of 1,456
77th

Pay ratio

James B. Weissman's Pay$3,312,612
Median Employee's Pay$311,375
Pay Ratio

11

to 1

In 2020, the annual total compensation of James B. Weissman was $3,312,612.

The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.

The ratio of James B. Weissman's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on April 20, 2021.

Weissman's colleagues

We found six more compensation records of executives who worked with James B. Weissman at Dicerna Pharmaceuticals in 2020.

2020

Douglas Fambrough

Dicerna Pharmaceuticals

Chief Executive Officer

2020

Ralf Rosskamp

Dicerna Pharmaceuticals

Chief Medical Officer

2020

John Green

Dicerna Pharmaceuticals

Chief Financial Officer

2020

Bob Brown

Dicerna Pharmaceuticals

Chief Scientific Officer

2020

Shreeram Aradhye

Dicerna Pharmaceuticals

Chief Medical Officer

2020

Douglas Pagán

Dicerna Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like